PKC-ing Is Believing Targeting Protein Kinase C in Heart Failure

被引：13

作者：

Belmonte, Stephen L. ^{[1
]}

Blaxall, Burns C. ^{[1
]}

机构：

[1] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Dept Med,Med Ctr, Rochester, NY 14642 USA

来源：

CIRCULATION RESEARCH | 2011年 / 109卷 / 12期

关键词：

CARDIAC CONTRACTILITY; ENDOTHELIAL-CELLS; BETA INHIBITOR; ALPHA; RUBOXISTAURIN; ACTIVATION; HYPERTROPHY;

D O I：

10.1161/CIRCRESAHA.111.259358

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1320 / 1322

页数：3

共 23 条

[1]

Aiello LP, 2007, ARCH OPHTHALMOL-CHIC, V125, P318

[2]

ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN Efficacy, Safety, and Causes of Vision Loss Among 813 Patients (1,392 Eyes) with Diabetic Retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein kinase C β Inhibitor-Diabetic Retinopathy Study 2 [J].

Aiello, Lloyd Paul ;

Vignati, Louis ;

Sheetz, Matthew J. ;

Zhi, Xin ;

Girach, Aniz ;

Davis, Matthew D. ;

Wolka, Anne M. ;

Shahri, Nazila ;

Milton, Roy C. .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (10) :2084-2094

[3]

Inhibition of PKC β by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients [J].

Aiello, LP ;

Clermont, A ;

Arora, V ;

Davis, MD ;

Sheetz, MJ ;

Bursell, SE .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (01) :86-92

[4]

PKC-α regulates cardiac contractility and propensity toward heart failure [J].

Braz, JC ;

Gregory, K ;

Pathak, A ;

Zhao, W ;

Sahin, B ;

Klevitsky, R ;

Kimball, TF ;

Lorenz, JN ;

Nairn, AC ;

Liggett, SB ;

Bodi, I ;

Wang, S ;

Schwartz, A ;

Lakatta, EG ;

DePaoli-Roach, AA ;

Robbins, J ;

Hewett, TE ;

Bibb, JA ;

Westfall, MV ;

Kranias, EG ;

Molkentin, JD .

NATURE MEDICINE, 2004, 10 (03) :248-254

[5]

The role of protein kinase C activation and the vascular complications of diabetes [J].

Das Evcimen, Net ;

King, George L. .

PHARMACOLOGICAL RESEARCH, 2007, 55 (06) :498-510

[6]

Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy [J].

Ferreira, Julio C. B. ;

Koyanagi, Tomoyoshi ;

Palaniyandi, Suresh S. ;

Fajardo, Giovanni ;

Churchill, Eric N. ;

Budas, Grant ;

Disatnik, Marie-Helene ;

Bernstein, Daniel ;

Brum, Patricia C. ;

Mochly-Rosen, Daria .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 51 (06) :980-987

[7]

Regulation of Protein Kinase C function by phosphorylation on conserved and non-conserved sites [J].

Freeley, Michael ;

Kelleher, Dermot ;

Long, Aideen .

CELLULAR SIGNALLING, 2011, 23 (05) :753-762

[8]

Protein kinase Cα negatively regulates systolic and diastolic function in pathological hypertrophy [J].

Hahn, HS ;

Marreez, Y ;

Odley, A ;

Sterbling, A ;

Yussman, MG ;

Hilty, KC ;

Bodi, I ;

Liggett, SB ;

Schwartz, A ;

Dorn, GW .

CIRCULATION RESEARCH, 2003, 93 (11) :1111-1119

[9]

Pharmacological- and gene therapy-based inhibition of protein kinase Cα/β enhances cardiac contractility and attenuates heart failure [J].

Hambleton, Michael ;

Hahn, Harvey ;

Pleger, Sven T. ;

Kuhn, Matthew C. ;

Klevitsky, Raisa ;

Carr, Andrew N. ;

Kimball, Thomas F. ;

Hewett, Timothy E. ;

Dorn, Gerald W., II ;

Koch, Walter J. ;

Molkentin, Jeffery D. .

CIRCULATION, 2006, 114 (06) :574-582

[10]

High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha [J].

Hempel, A ;

Maasch, C ;

Heintze, U ;

Lindschau, C ;

Dietz, R ;

Luft, FC ;

Haller, H .

CIRCULATION RESEARCH, 1997, 81 (03) :363-371

← 1 2 3 →